Date Initiated by Firm |
April 12, 2013 |
Date Posted |
July 15, 2013 |
Recall Status1 |
Terminated 3 on September 14, 2015 |
Recall Number |
Z-1735-2013 |
Recall Event ID |
65088 |
Product Classification |
Sera, animal and human - Product Code KIS
|
Product |
Various types of Fetal Bovine Serum
Bovine sourced Animal Sera for in-vitro diagnostic device and as a growth promoting nutrient in cell culture systems. |
Code Information |
510 k exempt No Medical Device Listing number All batches produced within the last 5 years (143 batches) |
Recalling Firm/ Manufacturer |
Paa Laboratories Inc 145 Bethridge Road Etobicoke Canada Ontario
|
For Additional Information Contact |
Mr. Jose A. Restituyo 508-683-2337
|
Manufacturer Reason for Recall |
Current product labeling band data sheets state that FBS Pharma Grade and FBS/FBS Native
are pure Fetal Bovine Serum (FBS). These products may contain added adult Bovine Serum
Albumin (BSA)of United States origin, water, and/or cell growth promoting additives. All other
FBS products, as listed below, including FBS Gold and FBS Standard, described as specialty
sera', may contain adult BSA of Un
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
GE Healthcare notified customers via USPS on April 12, 2013 and April 14, 2013. The letter identified the product, the problem, and the action to be taken by the customer. Customers being contacted by phone as well.
Customers were asked to contact their local customer service representative if the product does not meet their needs. Customers were instructed to call (732) 457-8455 or 301-660-0256.
For questions regarding this recall call 609-514-6888. |
Quantity in Commerce |
approximately 280,000 liters |
Distribution |
Worldwide Distribution - USA (nationwide), Novia Scotia, and Canada |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|